Skip to main content
. 2024 Nov 4;24:324. doi: 10.1186/s12911-024-02697-8

Table 4.

Description of the cohort of patients hospitalised for a THA, TKA or TSA between 2010 and 2019

THA TKA TSA
Centre I
(n = 1,811)
Centre II
(n = 2,302)
Centre I
(n = 1,362)
Centre II
(n = 1,268)
Centre I
(n = 499)
Centre II
(n = 345)
Sex ratio 0.99 0.81 0.80 0.69 0.49 0.41
Age, mean (SD) 66.8 (12.7) 65.5 (13.9) 69.1 (9.2) 68.6 (10.1) 70.1 (10.7) 68.6 (11.4)
Comorbidity, n(%)
Cancer 75 (4.1) 27 (1.2) 27 (1.9) 6 (0.5) 8 (1.6) 1 (0.3)
Cardiovascular disease 127 (7.0) 159 (6.9) 85 (6.2) 82 (6.5) 24 (4.8) 14 (4.0)
Diabetes 41 (2.3) 88 (3.8) 35 (2.6) 68 (5.4) 5 (1.0) 16 (4.6)
Hypertension 111 (6.1) 275 (11.9) 85 (6.2) 196 (15.4) 31 (6.2) 51 (14.8)
Neurological disease 42 (2.3) 53 (2.3) 25 (1.8) 23 (1.8) 14 (2.8) 15 (4.3)
Overweight 91 (5.0) 335 (14.5) 104 (7.6) 320 (25.2) 26 (5.2) 62 (17.9)
Other comorbidity 732 (40.4) 1,235 (53.6) 587 (43.1) 799 (63.0) 164 (32.9) 173 (50.1)

THA Total Hip Arthroplasty; TKA: Total Knee Arthroplasty; TSA: Total shoulder Arthroplasty; CPT: Current Procedure Terminology